DRAGARWQ (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Dr. Agarwal's Eye Hospital Limited |
|||
|
Price: ₹5,604.55 | ||
| 52 Week Low: ₹2,541.80 52 Week High: ₹5,790.00 |
|||
| Market Capital: 2,426.09 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: DRAGARWQ Share Price Target For 2024
- 1.1.1: DRAGARWQ Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: DRAGARWQ Share Price Target For 2025
- 1.2.1: DRAGARWQ Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: DRAGARWQ Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: DRAGARWQ Financial Performance
- 3.0.1: Is DRAGARWQ A Good Buy For Long Term?
To predict the DRAGARWQ's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
DRAGARWQ Share Price Target For 2024
The line chart displays the monthly closing prices of DRAGARWQ with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for DRAGARWQ shares in 2024, see the table below.
DRAGARWQ Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 5883.54 (+4.97%) | Price Action: Chart |
| 2024 Target 2 | 5773.84 (+3.02%) | Fibonacci Extension Level 23.60% |
| 2024 Target 1 | 5714.5 (+1.96%) | Price Action: 10 Dec 2024 High |
| Current Price | 5604.55 | DRAGARWQ's share price as of 23 Dec 2024 |
| Stop Loss 1 | 5551.0 (-0.96%) | Price Action: 10 Dec 2024 Low |
| Stop Loss 2 | 5468.05 (-2.44%) | Price Action: 05 Dec 2024 Low |
| Stop Loss 3 | 5412.8 (-3.43%) | Price Action: 23 Dec 2024 Low |
Short-Term Technical Outlook
Current Technical Position: DRAGARWQ is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹5357.41 serves as the nearest technical reference point.
Historical Returns: 3-month: +9.67% | 6-month: +73.63% | 1-year: +96.22%
DRAGARWQ Share Price Target For 2025
The line chart displays the monthly closing prices of DRAGARWQ with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for DRAGARWQ shares in 2025, see the table below.
DRAGARWQ Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 7948.45 (+41.82%) | Price Action: Chart |
| 2025 Target 2 | 7800.25 (+39.17%) | Price Action: Chart |
| 2025 Target 1 | 7723.02 (+37.79%) | Fibonacci Extension Level 64.90% |
| Current Price | 5604.55 | DRAGARWQ's share price as of 23 Dec 2024 |
| Stop Loss 1 | 5116.79 (-8.71%) | Price Action: 23 Oct 2024 Low |
| Stop Loss 2 | 5050.0 (-9.9%) | Price Action: 22 Nov 2024 High |
| Stop Loss 3 | 4990.0 (-10.97%) | Price Action: 25 Oct 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: DRAGARWQ is currently trading near its 52-week high of ₹5790, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +96.22% | 3-year: +729.89% | 5-year: +1,799.35%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
DRAGARWQ Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹5,604.55 | ||
| 2024 | ₹4,660.28 | -16.84% | ₹4,752.91 |
| 2025 | ₹7,864.55 | +68.75% | ₹7,982.52 |
| 2026 | ₹9,299.22 | +18.24% | ₹9,438.71 |
| 2027 | ₹10,851.93 | +16.69% | ₹11,014.71 |
| 2028 | ₹13,058.05 | +20.32% | ₹13,658.40 |
| 2029 | ₹14,395.59 | +10.24% | ₹16,555.32 |
| 2030 | ₹19,452.24 | +35.12% | ₹19,744.02 |
| 2031 | ₹19,882.17 | +2.21% | ₹20,180.40 |
| 2032 | ₹20,912.14 | +5.18% | ₹22,349.17 |
| 2033 | ₹23,270.04 | +11.27% | ₹25,246.09 |
| 2034 | ₹24,130.91 | +3.69% | ₹28,143.01 |
| 2035 | ₹31,039.93 | +28.63% | ₹31,505.53 |
| 2036 | ₹30,465.11 | -1.85% | ₹30,922.09 |
| 2037 | ₹30,972.35 | +1.66% | ₹33,936.86 |
| 2038 | ₹33,482.03 | +8.1% | ₹36,833.78 |
| 2039 | ₹35,613.81 | +6.36% | ₹39,730.70 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
DRAGARWQ Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 2,426.09 Crore | Market valuation of DRAGARWQ's shares. |
| Revenue (TTM) | 316.54 Crore | Total revenue generated by DRAGARWQ over the past twelve months. |
| Net Income (TTM) | +46.36 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +21.9% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +57.56% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+2.16% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
1.65 | Company's total debt divided by total shareholder equity. |
| Total Debt | 305.16 Crore | Sum of DRAGARWQ's current & long-term financial obligations. |
Is DRAGARWQ A Good Buy For Long Term?
DRAGARWQ, a small-cap stock with a market capitalization of ₹2,426.09 crore, shows strong recent performance: 78.83% return in the past 12 months and a remarkable 1727.16% over the past three years. However, a debt of ₹305.16 crore (Q2 2024-25) against a net profit of ₹46.36 crore (TTM) raises concerns. While the profit margin is high (14.6%), the significant debt warrants caution. For long-term investors, further investigation into the nature of the debt and future growth prospects is crucial before considering it a buy. It's currently a cautiously optimistic buy, not a strong buy.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
